ABBV AbbVie PE ratio, current and historical analysis
As at Oct 22, 2024, the ABBV stock has a PE ratio of 62.92. This is based on the current EPS of $3 and the stock price of $188.76 per share. An increase of 21% has been seen in the P/E ratio compared to the average of 52.2 of the last 4 quarters.
ABBV PE ratio history
The mean historical PE ratio of AbbVie over the last ten years is 28.83. The current 62.92 PE ratio is 118% above the historical average. Over the past ten years, ABBV's PE ratio was at its highest in the Dec 2014 quarter at 58.95, with a price of $65.44 and an EPS of $1.11. The Mar 2020 quarter recorded the bottom point at 13.44, with a price of $76.19 and an EPS of $5.67.
AbbVie PE ratio by year
Maximum annual increase: 187.98% in 2014
Maximum annual decrease: -68.09% in 2015
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 56.77 | 133.62% |
| 2022 | 24.3 | 16.27% |
| 2021 | 20.9 | -46.75% |
| 2020 | 39.25 | 134.89% |
| 2019 | 16.71 | -33.48% |
| 2018 | 25.12 | -14.03% |
| 2017 | 29.22 | 70.28% |
| 2016 | 17.16 | -8.77% |
| 2015 | 18.81 | -68.09% |
| 2014 | 58.95 | 187.98% |
ABBV average PE ratio chart
ABBV's current P/E ratio is above the 3, 5 and 10-year historical averages.
ABBV PE vs peers
ABBV's PE ratio is lower than its peer stocks LLY and GILD, but it is greater than AZN's and AMGN's. AbbVie's current PE ratio of 62.92 is above the average of its peers, which is 37.3.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 22.95 | $26.65B |
| NBIX Neurocrine Biosciences Inc | 33.55 | $11.62B |
| AZN Astrazeneca plc | 36.99 | $238.51B |
| AMGN Amgen Inc | 53.83 | $169.22B |
| ABBV AbbVie Inc | 62.63 | $331.88B |
| GILD Gilead Sciences Inc | 102.62 | $108.6B |
| LLY ELI LILLY & Co | 110.8 | $858.26B |
| PFE Pfizer Inc | N/A | $163.54B |
| BMY Bristol Myers Squibb Co | N/A | $107.57B |
Frequently asked questions
What is AbbVie's PE ratio?
As of Oct 22, 2024, ABBV stock has a price to earnings ratio of 62.92.
What is the 3-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 3 years is 34.69.
What is the 5-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 5 years is 30.82.
What is the highest PE ratio for ABBV?
Within the last ten years, the current P/E ratio is at its peak with a value of 62.92.
How does the current PE ratio for ABBV compare to its historical average?
ABBV's current price to earnings ratio is 118% above its 10-year historical average.
How is ABBV's PE ratio calculated (AbbVie PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Oct 22, 2024), AbbVie's stock price is $188.76. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $3. Therefore, AbbVie's P/E ratio for today is 62.92. PE RATIO(62.92) = STOCK PRICE($188.76) / TTM EPS($3)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.